C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 413/04 (2006.01) A61K 31/4245 (2006.01) C07D 413/06 (2006.01) C07D 413/12 (2006.01)
Patent
CA 2549955
Compounds of Formula (I), R1-A-V-B-R2; or pharmaceutically acceptable salts thereof, are agonists of GPR116 and are useful as regulators of satiety, e.g. for the treatment of obesity, and for the treatment of diabetes.
Selon l'invention, des composés de formule R?1¿-A-V-B-R?2¿ (I) ou des sels pharmaceutiquement acceptables desdits composés sont des agonistes de GPR116 et sont utiles comme régulateurs de la satiété, notamment pour le traitement de l'obésité et le traitement du diabète.
Fyfe Matthew
Gardner Lisa
King-Underwood John
Procter Martin
Rasamison Chrystelle
Macrae & Co.
Prosidion Limited
LandOfFree
Heterocyclic derivatives as gpcr receptor agonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Heterocyclic derivatives as gpcr receptor agonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heterocyclic derivatives as gpcr receptor agonists will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1617077